Your browser doesn't support javascript.
loading
Models predict change in plasma triglyceride concentrations and long-chain n-3 polyunsaturated fatty acid proportions in healthy participants after fish oil intervention.
Potter, Tilly I T; Horgan, Graham W; Wanders, Anne J; Zandstra, Elizabeth H; Zock, Peter L; Fisk, Helena L; Minihane, Anne M; Calder, Philip C; Mathers, John C; de Roos, Baukje.
Afiliación
  • Potter TIT; The Rowett Institute, University of Aberdeen, Aberdeen, United Kingdom.
  • Horgan GW; Biomathematics and Statistics Scotland, Aberdeen, United Kingdom.
  • Wanders AJ; Unilever Foods Innovation Centre, Wageningen, Netherlands.
  • Zandstra EH; Unilever Foods Innovation Centre, Wageningen, Netherlands.
  • Zock PL; Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, Netherlands.
  • Fisk HL; Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, Netherlands.
  • Minihane AM; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Calder PC; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
  • Mathers JC; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • de Roos B; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton, United Kingdom.
Front Nutr ; 9: 989716, 2022.
Article en En | MEDLINE | ID: mdl-36386924
ABSTRACT

Introduction:

Substantial response heterogeneity is commonly seen in dietary intervention trials. In larger datasets, this variability can be exploited to identify predictors, for example genetic and/or phenotypic baseline characteristics, associated with response in an outcome of interest.

Objective:

Using data from a placebo-controlled crossover study (the FINGEN study), supplementing with two doses of long chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs), the primary goal of this analysis was to develop models to predict change in concentrations of plasma triglycerides (TG), and in the plasma phosphatidylcholine (PC) LC n-3 PUFAs eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA), after fish oil (FO) supplementation. A secondary goal was to establish if clustering of data prior to FO supplementation would lead to identification of groups of participants who responded differentially.

Methods:

To generate models for the outcomes of interest, variable selection methods (forward and backward stepwise selection, LASSO and the Boruta algorithm) were applied to identify suitable predictors. The final model was chosen based on the lowest validation set root mean squared error (RMSE) after applying each method across multiple imputed datasets. Unsupervised clustering of data prior to FO supplementation was implemented using k-medoids and hierarchical clustering, with cluster membership compared with changes in plasma TG and plasma PC EPA + DHA.

Results:

Models for predicting response showed a greater TG-lowering after 1.8 g/day EPA + DHA with lower pre-intervention levels of plasma insulin, LDL cholesterol, C203n-6 and saturated fat consumption, but higher pre-intervention levels of plasma TG, and serum IL-10 and VCAM-1. Models also showed greater increases in plasma PC EPA + DHA with age and female sex. There were no statistically significant differences in PC EPA + DHA and TG responses between baseline clusters.

Conclusion:

Our models established new predictors of response in TG (plasma insulin, LDL cholesterol, C203n-6, saturated fat consumption, TG, IL-10 and VCAM-1) and in PC EPA + DHA (age and sex) upon intervention with fish oil. We demonstrate how application of statistical methods can provide new insights for precision nutrition, by predicting participants who are most likely to respond beneficially to nutritional interventions.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Nutr Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Nutr Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido